Ponoi Management, LLC
- SEC CIK
- 0001720702
- Latest filing
- Nov 14, 2022
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 4
- 0 vs. Q4 2021
- Portfolio value
- $77.0M
- −$31.4M (−29.0%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RAPTRAPT Therapeutics, Inc. | COM | 1,599,417 | $35.2M | 45.7% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 1,298,908 | $19.8M | 25.7% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 685,011 | $17.5M | 22.7% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 327,122 | $4.58M | 5.9% | 00.0% | Unchanged | History |